High levels of IL-30 in MDCs of tumor-draining lymph nodes from breast cancer patients have also proven to be an independent predictor of poor prognosis [9], thus suggesting the involvement of IL-30, produced by the host’s immune cells, in conditioning tumor behavior and patient outcome. This evidence concerns the gene IL27 and breast cancer.